Georgia McCaughan

Senior Research Associate

Specialties
 Clinical and Laboratory Haematology

Department
Haematology

Areas of Interest
Plasma cell disorders including multiple myeloma and AL amyloidosis

Roles
Staff Specialist Haematologist, St Vincent’s Public Hospital


VMO Haematologist, St Vincent’s Private Hospital


Senior Research Associate, University of New South Wales
 

PUBLICATIONS

Conference Abstracts
add
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Hamad N, 2024, 'A minority of women of childbearing potential are tested for pregnancy before chemoimmunotherapy: an Australian cancer centre experience', in Internal Medicine Journal, Vol. 54, pp. 750 - 754, http://dx.doi.org/10.1111/imj.16287
2024
Bryant C; Abadir E; Doo NW; Bryant A; McCaughan G; Yang S; Vanguru V; King T; Joshua D; Ho PJ, 2023, 'P-070 Failure to clear circulating tumor cells after one week of daratumumab, bortezomib and dexamethasone is associated with a reduced progression-free survival for myeloma patients', in Clinical Lymphoma Myeloma and Leukemia, Elsevier BV, Vol. 23, pp. S73 - S73, http://dx.doi.org/10.1016/s2152-2650(23)01688-9
2023
Gorrie N; McCaughan G; Carroll A; Jabbour A; Kotlyar E; Fatkin D; Bart N, 2022, 'Role of Endomyocardial Biopsy and Mass Spectrometry for Precision in Cardiac Amyloid Subtyping: A Case Series', in Heart, Lung and Circulation, Elsevier BV, Vol. 31, pp. S99 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.123
2022
Quach H; Lasica M; Routledge D; Kalff A; Lim A; Low M; Estell JA; Sidiqi MH; Campbell P; Eek RW; Lai HC; McCaughan GJ; D'Rozario J; Browlett P; Rajagopal R; Heenan J; Murphy NE; Renwick W; Huan G; Mollee P, 2021, 'A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS8055
2021
McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', in Blood, American Society of Hematology, Vol. 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269
2020
McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', in Blood, American Society of Hematology, Vol. 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991
2020
Journal articles
add
Gorrie N; Montgomery E; Kessler C; Fatkin D; McCaughan G; Bart NK; Carroll A, 2024, 'Diagnosing Transthyretin Amyloidosis: A single centre experience with histopathological diagnosis PB91 (#553)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f944
2024
Gorrie N; Montgomery E; Kessler C; Fatkin D; S. A; McCaughan G; Bart NK, 2024, 'Cardiac Magnetic Resonance Imaging for the early diagnosis of AL cardiomyopathy: A case series PB128 (#445)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f5b4
2024
Montgomery E; Gorrie N; Rye E; Kessler C; Fatkin D; Macdonald P; S. A; McCaughan G; Bart NK, 2024, 'The prevalence of frailty and association with disease severity in transthyretin amyloid cardiomyopathy PC40 (#265)', , http://dx.doi.org/10.26226/m.65f9bf8ae6f73964e1d4f00f
2024
Quach H; Lasica M; Low M; Mollee P; Lai HC; Wong Doo N; Hocking J; Campbell P; Murphy NE; Sidiqi MH; Routledge D; Heenan J; Horvath N; Eek R; Renwick WEP; Lenton DS; Child LJ; McCaughan G; Butcher BE; Mazumdar D; Kalff A, 2023, 'Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand)', Blood, 142, pp. 2023 - 2023, http://dx.doi.org/10.1182/blood-2023-185169
2023
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255
2023
Banerjee R; Kaur G; Wang B; Anderson LD; McCaughan G; Cowan AJ; Rajkumar SV, 2023, 'Standard-of-Care Bortezomib Dosing in Multiple Myeloma: An International Survey of Physicians', Blood, 142, pp. 5073 - 5073, http://dx.doi.org/10.1182/blood-2023-173772
2023
Lasica M; Spencer A; Horvath N; Janowski W; Coghlan D; Wallington-Gates C; Campbell P; Lai HC; McCaughan G; Weber N; Puliyayil A; Wong P; Yachao D; Le K; Reynolds J; Quach H, 2023, 'A Phase I/II Single Arm Study of Belantamab Mafodotin, Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Planned Interim Analysis of Safety and Efficacy. Amarc 19-02 Belacard Study', Blood, 142, pp. 2012 - 2012, http://dx.doi.org/10.1182/blood-2023-189005
2023
Hoff FW; Banerjee R; Khan A; McCaughan G; Wang XW; Roose J; Anderson LD; Cowan AJ; Rajkumar V; Kaur G, 2023, 'Retrospective Observational Study on Real-World Bortezomib Prescribing Patterns and Outcomes in Newly Diagnosed Multiple Myeloma', Blood, 142, pp. 544 - 544, http://dx.doi.org/10.1182/blood-2023-178950
2023
Moore E; Harrison S; Ho PJ; Irving A; King T; McCaughan G; McQuilten Z; Mollee P; Park S; Petrie D; Reynolds J; Rutherford C; van Tonder T; Wellard C; Wood E; Spencer A, 2023, 'P-476 More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial', Clinical Lymphoma Myeloma and Leukemia, 23, pp. S301 - S302, http://dx.doi.org/10.1016/s2152-2650(23)02093-1
2023
Moore E; Harrison S; Ho PJ; Irving A; King T; Mccaughan G; Mcquilten Z; Mollee P; Park S; Petrie D; Reynolds J; Rutherford C; van Tonder T; Wellard C; Wood E; Spencer A, 2023, 'PB2698: MORE EFFICIENT DELIVERY OF HIGH-COST STANDARD-OF-CARE THERAPIES IN RELAPSED MULTIPLE MYELOMA USING REAL-TIME FEEDBACK OF PATIENT-REPORTED OUTCOME MEASURES: THE MY-PROMPT-2 TRIAL', HemaSphere, 7, pp. e68933f0 - e68933f0, http://dx.doi.org/10.1097/01.hs9.0000977464.68933.f0
2023
Rajasekariah H; McCaughan G; Ma CKK; Gorrie N; Milliken S; Ma D; Fay K; Withers B; Hamad N; Birch S; Keogh A; Jabbour A; Hayward C; Macdonald P; Moore J, 2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319
2023
Banerjee R; Wang B; Anderson LD; McCaughan G; Mehra N; Cowan AJ; Rajkumar SV; Kaur G, 2023, 'Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians', Blood Cancer Journal, 13, http://dx.doi.org/10.1038/s41408-023-00937-0
2023
Jiang W; Clancy LE; Avdic S; Sutrave G; Street J; Simms R; McGuire HM; Patrick E; Chan AS; McCaughan G; Myers N; Micklethwaite KP; Antonenas V; Selim AG; Ritchie D; Bateman CM; Shaw PJ; Blyth E; Gottlieb DJ, 2022, 'Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant', Blood Advances, 6, pp. 4949 - 4966, http://dx.doi.org/10.1182/bloodadvances.2022007103
2022
Lasica M; Spencer A; Campbell P; Wallington-Gates C; Wong Doo N; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY.', HemaSphere, 6, pp. 836 - 837, http://dx.doi.org/10.1097/01.hs9.0000846652.51254.ac
2022
Lasica M; Spencer A; Campbell P; Wallington-Gates C; Doo NW; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study', Clinical Lymphoma Myeloma and Leukemia, 22, pp. S29 - S30, http://dx.doi.org/10.1016/s2152-2650(22)00321-4
2022
McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG, 2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, 199, pp. 190 - 204, http://dx.doi.org/10.1111/bjh.18295
2022
Chai KL; Wellard C; Aoki N; Moore EM; Augustson B; Bapat A; Blacklock HA; Chng WJ; Cooke R; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; Kim JS; Kim K; King T; McCaughan GJ; Mollee P; Morrissey CO; Murphy N; Quach H; Tan XN; Tso A; Wong K; Spencer A; Wood EM; McQuilten ZK, 2022, 'P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISEASES REGISTRIES (MRDR)', HemaSphere, 6, pp. 1454 - 1455, http://dx.doi.org/10.1097/01.hs9.0000849148.93868.54
2022
Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072
2022
Chai KL; Wellard C; Moore EM; Augustson B; Bapat A; Blacklock HA; Cooke RE; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; King T; McCaughan GJ; Mollee P; Morrissey O; Murphy NE; Quach H; Tan XN; Wong K; Spencer A; Wood EM; McQuilten Z, 2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', Blood, 138, pp. 4757 - 4757, http://dx.doi.org/10.1182/blood-2021-147622
2021
McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9
2021
McCaughan GJ; Tran S; Durrant S; Harrison S; Morton J; Horvath N; Spencer A; Kerridge IH; Ke Er JA; Barge L; Bryant A; Filshie R; Choong E; Lai HC; Tiley C; Mills A; Butler A; Moore J; Hertzberg M; Kennedy G; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee C; Kalff A; Xia W; Hamad N, 2021, 'Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S399 - S401, http://dx.doi.org/10.1016/s2666-6367(21)00515-7
2021
Hung D; Lenton D; Eslick R; Blennerhassett R; Joshi M; McCaughan G; Day S; Wright D, 2021, 'Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma', Genes Chromosomes and Cancer, 60, pp. 668 - 677, http://dx.doi.org/10.1002/gcc.22975
2021
Bishop DC; Clancy LE; Simms R; Burgess J; Mathew G; Moezzi L; Street JA; Sutrave G; Atkins E; McGuire HM; Gloss BS; Lee K; Jiang W; Maddock K; McCaughan G; Avdic S; Antonenas V; O'Brien TA; Shaw PJ; Irving DO; Gottlieb DJ; Blyth E; Micklethwaite KP, 2021, 'Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells', Blood, 138, pp. 1504 - 1509, http://dx.doi.org/10.1182/blood.2021010813
2021
Mills G; Tang C; Di Ciaccio PR; Chadwick VL; Withers B; Lavee O; Milliken S; Perram J; McCaughan GJ; Hamad N, 2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149354
2021
McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8
2021
McCaughan G; Jarvis S; Joseph J, 2021, 'Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series', Pathology, 53, pp. 798 - 800, http://dx.doi.org/10.1016/j.pathol.2020.11.005
2021
Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028
2021
McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247
2021
Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859
2020
McCaughan GJ; Crowther HJ; Chen V; Chunilal SD; Merriman E; Bortz H; Young L; Tran HA; Yuen HLA; Curnow J, 2020, 'Australian and New Zealand Registry of Anticoagulation in the Obese: Prescribing Patterns, Drug Levels and Patient Outcomes', Blood, 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-143150
2020
Favaloro EJ; McCaughan G; Mohammed S; Lau KKE; Gemmell R; Cavanaugh L; Donikian D; Kondo M; Brighton T; Pasalic L, 2018, 'HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia', Pathology, 50, pp. 426 - 436, http://dx.doi.org/10.1016/j.pathol.2017.11.089
2018
Favaloro EJ; McCaughan GJB; Mohammed S; Pasalic L, 2018, 'Anticoagulation therapy in Australia', Annals of Blood, 3, pp. 48 - 48, http://dx.doi.org/10.21037/aob.2018.12.02
2018
McCaughan GJB; Favaloro EJ; Pasalic L; Curnow J, 2018, 'Anticoagulation at the extremes of body weight: choices and dosing', Expert Review of Hematology, 11, pp. 817 - 828, http://dx.doi.org/10.1080/17474086.2018.1517040
2018
Blennerhassett R; McCaughan G; Tegg E, 2018, 'An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly', Pathology, 50, pp. 773 - 775, http://dx.doi.org/10.1016/j.pathol.2018.05.007
2018
McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016
2017
Favaloro EJ; McCaughan G; Pasalic L, 2017, 'Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update', Pathology, 49, pp. 346 - 355, http://dx.doi.org/10.1016/j.pathol.2017.02.005
2017
McCaughan GJB; Fulham MJ; Mahar A; Soper J; Hong AM; Stalley PD; Tattersall MHN; Bhadri VA, 2016, 'Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma', Journal of Hematology and Oncology, 9, http://dx.doi.org/10.1186/s13045-016-0278-x
2016
Mccaughan GJ; Blinman PL; Boyer MJ; Stockler MR, 2013, 'Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer', Internal Medicine Journal, 43, pp. 424 - 429, http://dx.doi.org/10.1111/j.1445-5994.2012.02846.x
2013
Kiely BE; McCaughan G; Christodoulou S; Beale PJ; Grimison P; Trotman J; Tattersall MHN; Stockler MR, 2013, 'Using scenarios to explain life expectancy in advanced cancer: Attitudes of people with a cancer experience', Supportive Care in Cancer, 21, pp. 369 - 376, http://dx.doi.org/10.1007/s00520-012-1526-4
2013
Stockler MR; Kiely BE; McCaughan GJ; Christodoulou S; Beale PJ; Trotman J; Grimison P; Tattersall MHN, 2012, 'Using scenarios to explain survival time: Attitudes of people with a cancer experience.', Journal of Clinical Oncology, 30, pp. 9126 - 9126, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9126
2012
Conference Papers
add
Kiely BE; McCaughan G; Christodoulou S; Tattersall MHN; Beale P; Grimison P; Stockler MR, 2011, 'P5-15-02: Patients' Views about How Oncologists Should Explain Prognosis in Advanced Cancer.', in Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/0008-5472.sabcs11-p5-15-02
2011
Organisational units
lensAssociate Investigators